Tamarack Advisers’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,000
| Closed | -$758K | – | 17 |
|
|
2023
Q2 | $758K | Buy |
2,000
+1,000
| +100% | +$379K | 0.23% | 26 |
|
|
2023
Q1 | $479K | Buy |
+1,000
| New | +$479K | 0.18% | 30 |
|
|
2022
Q4 | – | Sell |
-2,000
| Closed | -$834K | – | 34 |
|
|
2022
Q3 | $834K | Buy |
+2,000
| New | +$834K | 0.49% | 35 |
|
|
2021
Q3 | – | Sell |
-1,000
| Closed | -$644K | – | 39 |
|
|
2021
Q2 | $644K | Buy |
+1,000
| New | +$644K | 0.18% | 37 |
|
|
2020
Q4 | – | Sell |
-15,000
| Closed | -$7.73M | – | 41 |
|
|
2020
Q3 | $7.73M | Sell |
15,000
-15,000
| -50% | -$7.73M | 2.38% | 17 |
|
|
2020
Q2 | $13.5M | Sell |
30,000
-10,000
| -25% | -$4.52M | 3.77% | 10 |
|
|
2020
Q1 | $14M | Sell |
40,000
-60,000
| -60% | -$21M | 5.31% | 8 |
|
|
2019
Q4 | $36.7M | Sell |
100,000
-15,000
| -13% | -$5.5M | 8.38% | 2 |
|
|
2019
Q3 | $38.3M | Buy |
115,000
+15,000
| +15% | +$4.99M | 9.97% | 3 |
|
|
2019
Q2 | $30.9M | Buy |
100,000
+35,000
| +54% | +$10.8M | 9.4% | 3 |
|
|
2019
Q1 | $19.9M | Buy |
65,000
+5,000
| +8% | +$1.53M | 7.89% | 6 |
|
|
2018
Q4 | $13.9M | Sell |
60,000
-5,000
| -8% | -$1.16M | 5.68% | 9 |
|
|
2018
Q3 | $20.3M | Buy |
65,000
+10,000
| +18% | +$3.13M | 5.81% | 7 |
|
|
2018
Q2 | $15.9M | Buy |
55,000
+17,100
| +45% | +$4.93M | 5.31% | 8 |
|
|
2018
Q1 | $9.48M | Buy |
+37,900
| New | +$9.48M | 4.51% | 9 |
|
|
2017
Q1 | – | Sell |
-49,000
| Closed | -$8.93M | – | 31 |
|
|
2016
Q4 | $8.93M | Sell |
49,000
-59,000
| -55% | -$10.8M | 6.32% | 4 |
|
|
2016
Q3 | $17.5M | Buy |
108,000
+38,000
| +54% | +$6.16M | 5.51% | 5 |
|
|
2016
Q2 | $10M | Sell |
70,000
-30,000
| -30% | -$4.29M | 3.84% | 13 |
|
|
2016
Q1 | $13.7M | Sell |
100,000
-25,000
| -20% | -$3.42M | 4.79% | 11 |
|
|
2015
Q4 | $17.3M | Buy |
+125,000
| New | +$17.3M | 2.28% | 13 |
|